Who owns Trius Therapeutics?

Key details on Trius Therapeutics (Ticker: TSRX)

Who owns Trius Therapeutics?

Is TSRX a good stock to own? Find out who bought Trius Therapeutics, who sold Trius Therapeutics (TSRX) stock, and who holds a large position in Trius Therapeutics.

Fund Name Number of Shares Share Valuation As Of
Wellington Management Company 2.59M $21.03M June 30, 2013
FMR 1.73M $14.04M June 30, 2013
First Eagle Investment Management 1.67M $13.58M June 30, 2013
BlackRock Fund Advisors 1.38M $11.17M June 30, 2013
Broadfin Capital 1.21M $5.79M Dec. 31, 2012
UBS GLOBAL ASSET MANAGEMENT AMERICAS 1.13M $9.19M June 30, 2013
Sectoral Asset Management 1.00M $5.85M Sept. 30, 2012
Perceptive Advisors 920996 $6.59M Dec. 31, 2011
Thomas Weisel Asset Management 782942 $3.74M Dec. 31, 2012
Vanguard 659415 $5.36M June 30, 2013
Harvey Capital Management 549850 $4.45M June 30, 2013
Ayer Capital Management 509165 $2.72M March 31, 2012
BlackRock Institutional Trust Company, N.A. 468510 $3.79M June 30, 2013
STATE STREET CORPORATION 438104 $3.56M June 30, 2013
AXA 432496 $3.51M June 30, 2013
NORTHERN TRUST 431308 $3.49M June 30, 2013
CI Investments 427097 $2.46M June 30, 2012
Porter Orlin 418700 $54431 Dec. 31, 2013
Timberline Asset Management 380383 $2.60M March 31, 2013
Callan Capital 318096 $2.22M March 31, 2013
SUSQUEHANNA INTERNATIONAL 304563 $2.47M June 30, 2013
Wells Fargo & Company 302720 $2.47M June 30, 2013
BBT Capital Management 300931 $1.73M June 30, 2012
Manatuck Hill Partners 285000 $2.04M Dec. 31, 2011
Eudaimonia Asset Management 270881 $2.20M June 30, 2013
T. Rowe Price Associates 250000 $1.20M Dec. 31, 2012
Shott Capital Management 239233 $1.28M March 31, 2012
Technical Financial Services 235592 $1.91M June 30, 2013
Alyeska Investment 227500 $1.31M June 30, 2012
Frank Russell Company 222427 $1.72M June 30, 2013
Heather K. Mellem, Esq. 214639 $1.47M March 31, 2013
Balyasny Asset Management 213000 $1.46M March 31, 2013
TIAA-CREF Investment Management 210604 $1.71M June 30, 2013
HIGHBRIDGE CAPITAL MANAGEMENT 209816 $1.70M June 30, 2013
OrbiMed Advisors 209300 $1.50M Dec. 31, 2011
Diamondback Capital Management 203200 $1.18M Sept. 30, 2012
Dr. Jeffrey R. Jay, M.D 200000 $1.15M June 30, 2012
SMITH ASSET MANAGEMENT 189438 $905.51M Dec. 31, 2012
Millennium Management 189135 $1.53M June 30, 2013
PanAgora Asset Management 161907 $773915 Dec. 31, 2012
JPMORGAN CHASE & CO 155184 $1.26M June 30, 2013
Renaissance Technologies 148071 $852888 June 30, 2012
Schroder Investment Management 144929 $991314 March 31, 2013
Geode Capital Management 143619 $982353 March 31, 2013
GRT Capital Partners 138811 $1.12M June 30, 2013
Polar Capital 135899 $928190 March 31, 2013

Who sold Trius Therapeutics?

Fund Name Date Sold Number of Shares Sold Share Valuation
Redmile March 31, 2013 778250 $5.32M
Credit Suisse AG March 31, 2013 163888 $1.12M